A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis

B.J.F. van den Bemt, K. Vos, A.A. den Broeder, M. Blom, R.M. Thurlings, G.M. Bartelds, S.O. Stapel, P. Barrera, P.P. Tak, M.T. Nurmohamed, G. Wolbink

Research output: Contribution to journalArticleAcademicpeer-review

62 Downloads (Pure)
Original languageEnglish
Pages (from-to)1368-1369
Number of pages3
JournalAnnals of the Rheumatic Diseases
Volume68
Issue number8
DOIs
Publication statusPublished - 2009

Cite this

van den Bemt, B. J. F., Vos, K., den Broeder, A. A., Blom, M., Thurlings, R. M., Bartelds, G. M., ... Wolbink, G. (2009). A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 68(8), 1368-1369. https://doi.org/10.1136/ard.2008.095448